Trial site
Centre Hospitalier Régional Universitaire de Tours
- 174running trials
- 39closed trials
The trials here
What the 217 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma23 trials
- Lung cancer19 trials
- Childhood cancers18 trials
- Idiopathic pulmonary fibrosis13 trials
- Alzheimer disease9 trials
- Acute myeloid leukaemia8 trials
- Myelodysplastic syndromes8 trials
- Stroke7 trials
- Chronic lymphocytic leukaemia6 trials
- High blood pressure6 trials
- Multiple sclerosis6 trials
- Prostate cancer6 trials
- and 51 more
- Phase
- Phase 3119 trials
- Phase 257 trials
- Phase 2/315 trials
- Phase 413 trials
- Phase 14 trials
- Phase 1/24 trials
- Status
- Recruiting98 trials
- Active, not recruiting59 trials
- Completed39 trials
- Not yet recruiting17 trials
- Suspended4 trials
- Lead sponsor
- UNICANCER10 trials
- Assistance Publique Hopitaux De Paris9 trials
- Janssen Research & Development, LLC9 trials
- Assistance Publique - Hôpitaux de Paris8 trials
- AstraZeneca8 trials
- and 112 more
Running trials
Not yet recruiting
Not yet recruiting
Analysis of histological risk factors and biomarkers in paediatric retinoblastoma
Not yet recruiting
Not yet recruiting
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Not yet recruiting
Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
Not yet recruiting
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Recruiting
Recruiting
PALETTE - Trial for personalisation of sepsis treatment in children and adults
Recruiting
Recruiting
Lidocaine for opioid sparing in vaso-occlusive crisis of Sickle Cell Disease
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Recruiting
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Recruiting
Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
Not yet recruiting
Recruiting
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Recruiting
Recruiting
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Recruiting
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Showing 50 of 174.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers12 recruiting
- Lung cancer11 recruiting
- Multiple myeloma10 recruiting
- Multiple sclerosis5 recruiting
- Acute lymphoblastic leukaemia4 recruiting
- Alzheimer disease4 recruiting
- High blood pressure4 recruiting
- Idiopathic pulmonary fibrosis4 recruiting
- Stroke4 recruiting
- Acute myeloid leukaemia3 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Metastatic breast cancer3 recruiting
- Triple-negative breast cancer3 recruiting
- Asthma2 recruiting
- Brain aneurysm2 recruiting
- Chronic kidney disease2 recruiting
- Colorectal cancer2 recruiting
- Crohn's disease2 recruiting
- Haemophilia2 recruiting
- Lupus (SLE)2 recruiting
- Myelodysplastic syndromes2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Prostate cancer2 recruiting
- Systemic sclerosis (scleroderma)2 recruiting
- Ulcerative colitis2 recruiting
- ALS (motor neurone disease)1 recruiting
- Atrial fibrillation1 recruiting
- Chronic myeloid leukaemia1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Epilepsy1 recruiting
- Follicular lymphoma1 recruiting
- HIV1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Liver cirrhosis1 recruiting
- Mantle cell lymphoma1 recruiting
- Mesothelioma1 recruiting
- Narcolepsy1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoidosis1 recruiting
- Sarcoma1 recruiting
- Schizophrenia1 recruiting
- Sickle cell disease1 recruiting
Closed trials
Completed
Recruiting
Completed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Completed
Completed
Completed
Completed
Glenzocimab in Anterior stroke with Large Ischemic Core eligible for Endovascular therapy
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Recruiting
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
Completed
Completed
Completed
Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study
Completed
Active, not recruiting
Completed
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
Completed
Active, not recruiting
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Site data: ClinicalTrials.govUpdated 18 Nov 2026